Preoperative and Postoperative Sublingual Misoprostol for Prevention of Postpartum Blood Loss in Cesarean Section

Cesarean section is one of the most common major surgical operations among women. In 2015, the incidence of cesarean section in Woman Health Hospital in Assiut University accounts for 51.3 % of all deliveries

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postpartum Hemorrhage Female Urogenital Diseases and Pregnancy Complications Hemorrhage Obstetric Labor Complications Pathologic Processes Pathological Conditions, Signs and Symptoms Pregnancy Complications Puerperal Disorders Urogenital Diseases Uterine Hemorrhage

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Ahmed Abbas

Assiut, Cairo Governorate, 002, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All pregnant women who will undergo elective lower segment cesarean section
term ( ≥ 37 weeks)
normal fetal heart tracing.

Exclusion criteria

Placenta previa-Rupture uterus
Classical cesarean section
Preterm delivery
Hypertensive disorders of pregnancy
Bleeding tendency
Previous history of postpartum hemorrhage
Concurrent anticoagulant therapy
Concurrent long-term use of steroids
Fetal distress
Antepartum haemorrhage

Treatment and study plan

Misoprostol

Drug

Oral tablets

Primary outcomes

mean intraoperative blood loss

Time frame: 24 hours

Blood loss estimation will commence immediately following the skin incision

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Comparison Between Preoperative and Postoperative Sublingual Misoprostol for Prevention of Postpartum Blood Loss in Cesarean Section : a Randomized Clinical Trial

Important dates

Study start: 2018
Primary completion: 2018
Study completion: 2018
First posted: Jul 19, 2018
Registry last updated: Sep 18, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed